Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Babu

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Therapeutic Advances in Medical Oncology|August 13, 2020
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7)Nadia Harbeck, Fabio Franke, Rafael Villanueva-Vazquez, et al.
Journal of Cancer Research and Therapeutics|September 16, 2021
Metastatic hormone receptor-positive breast cancer in CDK 4/6 era: An outcome auditRajeev Krishnappa Lakkavalli, Jitendra Kumar Pehalajani, Venkatesh Tirumala, et al.
European Journal of Medicinal Chemistry|October 16, 2001
Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agentsG R Madhavan, R Chakrabarti, S K Kumar, et al.
Diabetes, Obesity & Metabolism|February 23, 2026
Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12-month observational cohort studyJoaquin Lado-Abeal, Francisco Gude, Maria Jose Ginzo-Villamayor, et al.
Indian Journal of Cancer|July 20, 2011
Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from IndiaP M Parikh, S Gupta, B Parikh, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Nature Communications|February 28, 2015
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneityBiswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, et al.
Epilepsia|March 25, 2010
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsyRobert Fisher, Vicenta Salanova, Thomas Witt, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Therapeutic Advances in Medical Oncology|August 13, 2020
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7)Nadia Harbeck, Fabio Franke, Rafael Villanueva-Vazquez, et al.
Journal of Cancer Research and Therapeutics|September 16, 2021
Metastatic hormone receptor-positive breast cancer in CDK 4/6 era: An outcome auditRajeev Krishnappa Lakkavalli, Jitendra Kumar Pehalajani, Venkatesh Tirumala, et al.
European Journal of Medicinal Chemistry|October 16, 2001
Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agentsG R Madhavan, R Chakrabarti, S K Kumar, et al.
Diabetes, Obesity & Metabolism|February 23, 2026
Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12-month observational cohort studyJoaquin Lado-Abeal, Francisco Gude, Maria Jose Ginzo-Villamayor, et al.
Indian Journal of Cancer|July 20, 2011
Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from IndiaP M Parikh, S Gupta, B Parikh, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Nature Communications|February 28, 2015
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneityBiswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, et al.
Epilepsia|March 25, 2010
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsyRobert Fisher, Vicenta Salanova, Thomas Witt, et al.
Pageof 14